IMproved PRegnancy Outcome by Early Detection
NCT01891240 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2016-11-08
Summary
The overall objective of the IMPROvED project is to develop a sensitive, specific, high-throughput and economically viable early pregnancy screening test for preeclampsia.
This will involve a multicentre, phase IIa clinical predictive study to assess and refine novel and innovative prototype tests based on emerging metabolomic and proteomic technologies developed by SMEs (small to medium size enterprise) within the consortium. The study will i) recruit 5000 first-time pregnant women; ii) establish a high calibre biobank, augmented by accurate clinical metadata; iii) determine whether prototype predictive assays and algorithms translate to the clinical environment; iv) assess potential synergy of a combined metabolomic and proteomic approach and v) progress regulatory approval and development of the selected test into the clinical arena.
Conditions
- Pre-eclampsia
- Pregnancy
- Pregnancy, High-risk
- Pregnancy Complications
Sponsors & Collaborators
-
Keele University
collaborator OTHER -
University of Liverpool
collaborator OTHER -
Karolinska University
collaborator OTHER - collaborator OTHER
-
Copenhagen Trial Unit, Center for Clinical Intervention Research
collaborator OTHER -
MedSciNet AB, Stockholm, Sweden
collaborator UNKNOWN -
MyCartis, Ghent, Belgium
collaborator UNKNOWN -
Metabolomic Diagnostics Ltd, Cork, Ireland
collaborator UNKNOWN -
Accelopment AG
collaborator OTHER -
University of Groningen, The Netherlands
collaborator UNKNOWN -
INFANT centre, University College Cork, Republic of Ireland
collaborator UNKNOWN -
Louise Kenny
lead OTHER
Principal Investigators
-
Louise Kenny, Professor · INFANT Centre, University College Cork, Ireland
-
Philip N Baker, Professor · Keele Univeristy School of Medicine
Eligibility
- Min Age
- 16 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-11-30
- Primary Completion
- 2017-10-31
- Completion
- 2018-04-30
Countries
- Ireland
- Netherlands
- Sweden
- United Kingdom
Study Locations
More Related Trials
-
LimPrOn: Limburg Pre-eclampsia Investigation
NCT03509272 ·Status: RECRUITING ·Phase: NA
-
Pre-eclampsia and Metabolomics
NCT00939575 ·Status: UNKNOWN
-
Placental Growth Factor Assessment of Women With Suspected Pre-eclampsia
NCT02881073 ·Status: COMPLETED ·Phase: NA
-
Prospective Study in Pregnant Women With Hypercoagulopathy
NCT00215969 ·Status: UNKNOWN
-
Non-Invasive Preeclampsia Screening and Biobank
NCT06643741 ·Status: RECRUITING
-
Preeclampsia and Circulating Biomarkers
NCT02136667 ·Status: UNKNOWN
-
First-trimester Prediction of Preeclampsia
NCT02189148 ·Status: COMPLETED
-
Validation of the MaiRa Preeclampsia Test for Screening Early/Late Preeclampsia in First and Second Trimesters
NCT06716242 ·Status: RECRUITING
-
Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy
NCT04075708 ·Status: COMPLETED
-
Blood Collection to Validated New Therapeutics Strategies Against Preeclampsia
NCT03188900 ·Status: COMPLETED
-
Preeclampsia Subtypes and Surrogate Markers of CVD Risk
NCT02337049 ·Status: UNKNOWN
-
Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia
NCT06220721 ·Status: RECRUITING ·Phase: NA
-
Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia
NCT06802861 ·Status: RECRUITING
-
Blood Pressure, Antihypertensive Treatment and Preeclampsia in Pregnant Wom-en With Pre-existing Diabetes
NCT02890836 ·Status: COMPLETED
-
Impedance Cardiography to Decrease the Risk of Preeclampsia
NCT03245970 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
PREPARE, Prematurity Reduction by Pre-eclampsia Care
NCT03073317 ·Status: COMPLETED ·Phase: NA
-
Randomizated Open-label Control Trial to Evaluate if the Incorporation of sFlt1/PlGF Ratio in the Diagnosis and Classification of PE Improves Maternal and Perinatal Outcomes in Women With the Suspicion of the Disease
NCT03231657 ·Status: COMPLETED ·Phase: NA
-
Serum LncRNAs as Early Potential Biomarkers for the Prediction of Preeclampsia
NCT03903393 ·Status: UNKNOWN
-
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
NCT03767803 ·Status: UNKNOWN
-
Treatment Targets for Chronic Hypertension in Pregnancy
NCT00194974 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Vascular Biomarkers Predictive of the Progression From Hypertensive Disorders in Pregnancy to Preeclampsia in Pregnant Women
NCT04520048 ·Status: RECRUITING ·Phase: NA
-
Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers
NCT02780414 ·Status: COMPLETED
-
Identifying Biomarkers for Endothelial Dysfunction in Women With Preeclampsia
NCT07084727 ·Status: RECRUITING ·Phase: NA
-
Molecular Study of the Maternal-fetal Interface in Preeclampsia.
NCT06232668 ·Status: RECRUITING
-
A Study to Evaluate the Use of Placenta Protein 13 (PP13) in the First Trimester of Pregnancy as a Diagnostic Aiding Tool in the Assessment of the Risk for Developing Preeclampsia in Women With Low and Unknown Risk
NCT00572793 ·Status: COMPLETED